Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immune Therapeutics Inc (OTCQB:IMUN)

During the Trading Day
0.014 +0.0015 / +12.00%
As of 3:25pm ET
Day’s Change
During After-Hours   Switch to standard view »
0.014 0.00 / 0.00%
Volume: --
Health Technology

Company Description

Immune Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing therapeutics to treat cancer, HIV or AIDS, autoimmune diseases and immune disorders by combating these chronic and often life-threatening diseases through the stimulation and regulation of the body's immune system. The company was founded by Noreen Griffin on December 2, 1993 and is headquartered in Orlando, FL.

Contact Information

Immune Therapeutics, Inc.
37 North Orange Avenue
Orlando Florida 32801
P:(888) 613-8802
Investor Relations:



Individual stakeholders6.28%
Mutual fund holders--
Other institutional--

Top Executives

Noreen GriffinChairman & Chief Executive Officer
Rudy J. WilliamsChief Operating Officer
Peter J. AronstamChief Financial Officer
Fengping ShanChief Science Officer
Joseph M. FortunakVice President-Global Research & Development